Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Psychosocial teleassistance programme for adults with spina bifida

Official title: Effects of a Psychosocial Teleassistance Programme for Adults With Spina Bifida

Run by University of Deusto · NCT07178873 · Data updated 2026-11-12

This study tests a 10-week group telecare psychological program to see if it improves self-esteem, social skills, and overall psychological well-being in adults with spina bifida.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment35 (estimated)
SponsorUniversity of Deusto
Academic / other
Locations1 site (Bilbao, Bizkaia)
StatusRecruiting
StartedJune 25, 2024
Main results expectedJanuary 2027
Study endsJanuary 2027
Registry record updatedDecember 10, 2025
Trial IDNCT07178873 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18–75 with a specialist diagnosis of spina bifida who speak Spanish, can provide informed consent, and have a computer with camera/microphone and internet access for videoconference sessions.

Probably not a fit

Patients with comorbid diagnoses or sensory deficits that prevent meaningful participation in group videoconference activities, non-Spanish speakers, or those without required technology are unlikely to benefit from this programme.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The programme delivers a structured psychosocial intervention via videoconference consisting of ten weekly 1.5-hour group sessions for 6–7 participants, followed by two follow-up sessions at three-month intervals. Outcomes include quality of life, self-esteem, self-concept, anxious-depressive symptoms, interpersonal needs, and coping strategies measured before and after the intervention and at follow-up. Participants must be 18–75 years old, diagnosed with spina bifida, Spanish-speaking, able to consent, and have computer and internet access. The intervention is developed and run by the University of Deusto in Bilbao and focuses on strengthening social skills and psychological resources through group teleassistance.

Why it matters

Potential benefit: If successful, the programme could raise self-esteem and social skills, reduce anxiety or depressive symptoms, and improve overall quality of life for participating adults with spina bifida.

How similar studies have gone: Telehealth psychosocial interventions have shown promise in chronic neurological and disability populations, but structured teleassistance specifically targeted to adults with spina bifida remains relatively novel and less well studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* To be diagnosed with spina bifida by a specialist.
* Being between 18 and 75 years old.
* Having their informed consent or the informed consent of their legal guardians.
* Having Spanish as one of their main languages.
* Having access to a computer (with a camera, microphone and speakers integrated) and Internet connection to take part in the videoconferences.

Exclusion Criteria:

* Age that is inconsistent with the established range.
* The presence of any comorbid diagnosis or sensory deficit that would impede the effective execution of the intervention's activities.

Where it's running

  • University of Deusto
    Bilbao, Bizkaia, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.